early colorectal cancer
Conditions
Interventions
Advanced colorectal cancer group:None
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Colorectal cancer group and colorectal adenoma 1. Colonoscopy at the Endoscopy Center of Peking University First Hospital; 2. Complete clinical data; 3. Sign the informed consent form; 4. Age >=18 and = 18 and<= 80 years old 5. No known malignant tumors other than colorectal
Exclusion criteria
Exclusion criteria: Colorectal cancer group and colorectal adenoma Exclusion Criteria (one of the following): 1. Age 80 years old; 2. Known concurrent or previous malignant tumors at other sites other than colorectal cancer; 3. Have undergone endoscopic, surgical or chemoradiotherapy treatment; 4. Do not agree to participate in the study or have incomplete clinical data; 5. Combined with metabolic diseases or hematologic diseases; 6. Combined with underlying diseases such as cardiovascular and cerebrovascular, liver, kidney, etc.; 7. Lactating or pregnant women; 8. Significant stress response within 2 weeks of blood collection; 9. Any symptoms of acute illness within 2 weeks of blood collection; 10. Have taken special drugs (antibiotics, hormones, non-steroidal anti-inflammatory drugs, etc.) within 2 weeks of blood collection Healthy control group 1. Age 80 years old; 2. Known concurrent or previous malignant tumors at other sites other than colorectal cancer; 3. Have undergone endoscopic, surgical or chemoradiotherapy treatment; 4. Do not agree to participate in the study or have incomplete clinical data; 5. Combined with metabolic diseases or hematologic diseases; 6. Combined with underlying diseases such as cardiovascular and cerebrovascular, liver, kidney, etc.; 7. Lactating or pregnant women 8. Significant stress response within 2 weeks of blood collection; 9. Any symptoms of acute illness within 2 weeks of blood collection; 10. Have taken special drugs (antibiotics, hormones, non-steroidal anti-inflammatory drugs, etc.) within 2 weeks of blood collection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological findings;Information on endoscopy; | — |
Secondary
| Measure | Time frame |
|---|---|
| general data; | — |
Countries
China
Contacts
Public ContactFeng Wang
Peking University First Hospital
Outcome results
None listed